Nek5 Activators
Nek5 Activators denote a range of compounds that can enhance the functionality of Nek5, a protein kinase involved in various cellular processes including cell cycle progression and apoptosis. These compounds primarily exert their influence by manipulating various biological processes and pathways closely associated with the functional role of Nek5. For instance, Purvalanol A and Roscovitine are selective inhibitors of cyclin-dependent kinases (CDKs). Nek5, being a member of the NIMA (Never In Mitosis gene A)-related kinase family, has structural relatednessto CDKs, and their inhibition can indirectly augment the relative activity of Nek5.
Other notable examples include SP600125 and PD98059, which are inhibitors of c-Jun N-terminal kinase (JNK) and mitogen-activated protein kinase kinase (MEK), respectively. Both JNK and MEK play integral roles in overlapping cellular processes that Nek5 regulates, such as cell cycle progression. By inhibiting these kinases, the relative activity of Nek5 can be enhanced, resulting in increased functionality of the protein. Similarly, compounds like BAY 11-7082, Y-27632, and ML-7, which inhibit IκB kinase (IKK), Rho-associated, coiled-coil containing protein kinase (ROCK), and myosin light chain kinase (MLCK) respectively, can shift the balance of processes such as NF-κB signaling and actin cytoskeleton regulation towards Nek5-mediated regulation. This shift enhances the functional activity of Nek5 within these processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Purvalanol A | 212844-53-6 | sc-224244 sc-224244A | 1 mg 5 mg | $72.00 $297.00 | 4 | |
Purvalanol A is a selective inhibitor of cyclin-dependent kinases (CDKs). Nek5 is a member of the NIMA (Never In Mitosis gene A)-related kinase family, which is structurally related to CDKs. By inhibiting CDKs, Purvalanol A can increase the relative activity of Nek5, enhancing its function. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a potent inhibitor of CDKs. Similar to Purvalanol A, by inhibiting these kinases, Roscovitine may enhance the relative activity of Nek5. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of c-Jun N-terminal kinase (JNK). JNK is involved in numerous cellular processes that overlap with those regulated by Nek5, including cell cycle progression and apoptosis. Inhibition of JNK can shift the balance of these processes towards Nek5-mediated regulation, enhancing its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK). MEK is involved in the regulation of cell proliferation, a process that is also regulated by Nek5. By inhibiting MEK, PD98059 can enhance the relative activity of Nek5 in this process. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an IκB kinase (IKK) inhibitor. IKK regulates NF-κB signaling, a pathway that can interact with Nek5-mediated processes. By inhibiting IKK, BAY 11-7082 can enhance the relative activity of Nek5. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated, coiled-coil containing protein kinase (ROCK). ROCK is involved in actin cytoskeleton regulation, a process that may be co-regulated by Nek5. Inhibiting ROCK can enhance the relative activity of Nek5 in this process. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK). MLCK is involved in cell shape changes and motility, processes that may also be regulated by Nek5. By inhibiting MLCK, ML-7 can enhance the relative activity of Nek5 in these processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. p38 MAPK is involved in numerous cellular processes that overlap with those regulated by Nek5, including cell cycle progression and apoptosis. Inhibition of p38 MAPK can shift the balance of these processes towards Nek5-mediated regulation, enhancing its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K regulates numerous cellular processes that can interact with Nek5-mediated processes. By inhibiting PI3K, LY294002 can enhance the relative activity of Nek5. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG-490 is a JAK2 inhibitor. JAK2 is involved in numerous cellular processes that overlap with those regulated by Nek5, including cell cycle progression and apoptosis. Inhibition of JAK2 can shift the balance of these processes towards Nek5-mediated regulation, enhancing its function. | ||||||